Skip to main content
Kane Biotech Inc. logo

Kane Biotech Inc. — Investor Relations & Filings

Ticker · KNE ISIN · CA4838092084 TSXV Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2025-06-04 Proxy Solicitation & In…
Country CA Canada
Listing TSXV KNE

About Kane Biotech Inc.

https://kanebiotech.com/

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of proprietary technologies designed to prevent and remove microbial biofilms, which are a major contributor to chronic infections and impaired healing. The company holds extensive intellectual property related to biofilm formation and dispersal mechanisms, utilizing proprietary technologies such as DispersinB® and coactiv+®. Its primary commercial focus is advanced wound care, where products like the revyve® Antimicrobial Wound Gel and Spray are designed to disrupt biofilms and promote healing. The product pipeline also includes surgical and dermatological applications for both human and animal health.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy appointment for shareholders to vote at the Annual and Special Meeting of Kane Biotech Inc. It solicits votes, provides instructions for submitting a proxy, and outlines resolutions to be voted on. This matches the definition of Proxy Solicitation & Information Statement (PSI) rather than the meeting materials or results, making PSI the correct classification.
2025-06-04 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a shareholder consent form for electronic delivery of corporate documents (annual reports, interim financial statements, meeting notices, proxy forms). It is not itself a financial report, proxy statement, AGM material, or any other specific filing type. It’s essentially a miscellaneous regulatory communication to shareholders, so it falls into the fallback category "Regulatory Filings" (RNS).
2025-06-04 English
Other.pdf
Regulatory Filings Classification · 0% confidence The document is a shareholder mailing list request form, enabling shareholders to elect to receive interim financial statements and MD&A by mail. It is not the actual interim report (IR), nor an announcement of report publication timing (RPA), nor any other specific filing category (e.g., AGM materials, earnings release, proxy solicitation). It serves a regulatory compliance purpose but does not neatly fit any specialized category, making it a fallback general regulatory filing.
2025-06-04 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a mailing list request form enabling shareholders to opt in to receive interim/annual financial statements and MD&A by mail. It is not the actual financial report (i.e., not an Annual Report, Interim Report, or MD&A), nor is it an earnings release or governance proxy. Instead, it is a shareholder communication regarding report distribution logistics. This type of notice does not fit any specific category beyond a general regulatory announcement, so it falls under Regulatory Filings (RNS) as a fallback.
2025-06-04 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a certification under NI 52-109 (Certification of Annual Filings) by the Interim CEO for the year ended December 31, 2024. It is not the full annual report (10-K) nor an earnings release, board change, or financing update. It is a required regulatory certificate rather than a financial statement or presentation. This type of stand-alone regulatory compliance filing best fits the general “Regulatory Filings” category (RNS).
2025-04-28 English
52-109FV1 - Certification of annual filings - CFO (F).pdf
Regulatory Filings Classification · 1% confidence The document is a certification letter by the CFO under NI 52-109 for the annual filings (AIF, annual financial statements and MD&A) of Kane Biotech Inc. It is not the Annual Report itself nor an audit report, but a regulatory certificate filing required by securities legislation. It does not announce publication of a report or detail financial results, so it best fits the fallback category for general regulatory filings.
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.